NL174349C - Werkwijze voor de bereiding van derivaten van 2-amino-1-pyridylethanol en werkwijze voor de bereiding van preparaten die ze bevatten. - Google Patents

Werkwijze voor de bereiding van derivaten van 2-amino-1-pyridylethanol en werkwijze voor de bereiding van preparaten die ze bevatten.

Info

Publication number
NL174349C
NL174349C NLAANVRAGE7201471,A NL7201471A NL174349C NL 174349 C NL174349 C NL 174349C NL 7201471 A NL7201471 A NL 7201471A NL 174349 C NL174349 C NL 174349C
Authority
NL
Netherlands
Prior art keywords
preparing
pyridylethanol
amino
preparations containing
derivatives
Prior art date
Application number
NLAANVRAGE7201471,A
Other languages
English (en)
Other versions
NL7201471A (nl
NL174349B (nl
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NL7201471A publication Critical patent/NL7201471A/xx
Publication of NL174349B publication Critical patent/NL174349B/nl
Application granted granted Critical
Publication of NL174349C publication Critical patent/NL174349C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NLAANVRAGE7201471,A 1971-02-16 1972-02-04 Werkwijze voor de bereiding van derivaten van 2-amino-1-pyridylethanol en werkwijze voor de bereiding van preparaten die ze bevatten. NL174349C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11587871A 1971-02-16 1971-02-16
US25664172A 1972-05-25 1972-05-25

Publications (3)

Publication Number Publication Date
NL7201471A NL7201471A (nl) 1972-08-18
NL174349B NL174349B (nl) 1984-01-02
NL174349C true NL174349C (nl) 1984-06-01

Family

ID=26813670

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7201471,A NL174349C (nl) 1971-02-16 1972-02-04 Werkwijze voor de bereiding van derivaten van 2-amino-1-pyridylethanol en werkwijze voor de bereiding van preparaten die ze bevatten.

Country Status (9)

Country Link
US (2) US3700681A (nl)
AT (1) AT315842B (nl)
BE (1) BE778771A (nl)
CA (1) CA978962A (nl)
CH (1) CH541560A (nl)
DE (2) DE2204195C2 (nl)
FR (1) FR2125309B1 (nl)
GB (2) GB1367668A (nl)
NL (1) NL174349C (nl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207639A1 (es) * 1973-12-26 1976-10-22 Pfizer Un procedimiento para preparar pirido (3,2-d)1,3-dioxin-6-epoxietanos y compuestos intermediarios desprovistos de actividad terapeutica
US3952101A (en) * 1975-04-14 1976-04-20 Smithkline Corporation α-Amino methyl-5-hydroxy-2-pyridinemethanols
US4011231A (en) * 1975-10-03 1977-03-08 Pfizer Inc. 2-Phenyl-6-(1-hydroxy-2-t-butylaminoethyl)-4H-pyrido[3,2-d]-1,3-dioxin maleate and its use as an intermediate
SE7708307L (sv) * 1976-08-26 1978-02-27 Pfizer Forfarande for framstellning av farmaceutiska kompositioner anvendbara sasom bronkodilatorer
US4175128A (en) * 1979-01-03 1979-11-20 Pfizer Inc. Method for treating congestive heart failure
SU1194273A3 (ru) * 1981-02-09 1985-11-23 Пфайзер Инк (Фирма) Способ получени пирбутерола или его аналогов
US4632992A (en) * 1981-02-09 1986-12-30 Pfizer Inc. Intermediates for preparing pirbuterol and analogs
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
EP0220054A3 (en) * 1985-10-16 1987-12-02 Glaxo Group Limited Ethanolamine derivatives
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
AU2305092A (en) * 1991-06-26 1993-01-25 Sepracor, Inc. Methods and compositions for treating pulmonary and cardiac disorders using optically pure (+) pirbuterol
WO1993000091A1 (en) * 1991-06-26 1993-01-07 Sepracor, Inc. Methods and compositions for treating pulmonary and cardiac disorders using optically pure (-)pirbuterol
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
JP2007504123A (ja) * 2003-08-29 2007-03-01 ランバクシー ラボラトリーズ リミテッド Ｉｖ型ホスホジエステラーゼの阻害剤
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
WO2005092860A1 (en) * 2004-03-23 2005-10-06 Pfizer Limited Compounds for the treatment of diseases
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
WO2007045980A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
MY155277A (en) * 2006-08-22 2015-09-30 Ranbaxy Lab Ltd Matrix metalloproteinase inhibitors
US20110021473A1 (en) * 2006-09-22 2011-01-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
MX2009009793A (es) 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN103119030A (zh) 2010-07-30 2013-05-22 兰贝克赛实验室有限公司 基质金属蛋白酶抑制剂
KR20130140688A (ko) 2010-09-24 2013-12-24 랜박시 래보러터리스 리미티드 기질 메탈로프로테나제 저해제
CN103848781B (zh) * 2012-11-30 2017-06-30 重庆华邦制药有限公司 高选择性氧化二羟甲基吡啶中一个羟甲基的方法
NZ707752A (en) 2012-12-03 2020-01-31 Pfizer Novel selective androgen receptor modulators

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1089189A (en) * 1964-09-23 1967-11-01 Koninklijke Pharma Fab Nv Ethers of -(2-pyridyl)benzyl alcohols

Also Published As

Publication number Publication date
FR2125309B1 (nl) 1976-05-14
BE778771A (fr) 1972-08-01
US3700681A (en) 1972-10-24
GB1367668A (en) 1974-09-18
NL7201471A (nl) 1972-08-18
DE2204195A1 (de) 1972-08-17
AT315842B (de) 1974-06-10
FR2125309A1 (nl) 1972-09-29
DE2265581C2 (de) 1982-07-01
DE2204195C2 (de) 1981-11-19
CH541560A (fr) 1973-10-31
CA978962A (en) 1975-12-02
GB1367669A (en) 1974-09-18
NL174349B (nl) 1984-01-02
US3763173A (en) 1973-10-02

Similar Documents

Publication Publication Date Title
NL174349C (nl) Werkwijze voor de bereiding van derivaten van 2-amino-1-pyridylethanol en werkwijze voor de bereiding van preparaten die ze bevatten.
NL149210B (nl) Werkwijze voor de bereiding van poederlakpreparaten.
NL7501032A (nl) Werkwijze ter bereiding van anti-tuberkelmid- delen, alsmede farmaceutische preparaten die deze middelen bevatten.
NL156404B (nl) Werkwijze voor de bereiding van chromanderivaten.
NL167963C (nl) Werkwijze voor de bereiding van onkruid verdelgende preparaten, die thiadiazolylureumverbindingen bevatten, en werkwijze voor de bereiding van dergelijke thiadiazolylureumverbindingen.
NL7514255A (nl) Werkwijze voor de bereiding van piperidylindolen en farmaceutische preparaten die ze bevatten.
NL148317B (nl) Werkwijze voor de bereiding van benzo (b) thiofeenazijnzuurderivaten, en van preparaten die ze bevatten.
NL170285C (nl) Werkwijze voor de bereiding van verbindingen met antiallergische werking en werkwijze voor de bereiding van preparaten die ze bevatten.
NL160828C (nl) Werkwijze voor de bereiding van anti-bacteriele 7-acrylglycyl cefalosporine-derivaten en preparaten die ze bevatten.
NL7514446A (nl) Werkwijze voor de bereiding van prostaglandines en van preparaten die ze bevatten.
NL175827C (nl) Werkwijze voor het bereiden van alfa-(5-indanyloxycarbonyl)-benzylpenicilline en van farmaceutische preparaten daaruit.
NL172163C (nl) Werkwijze voor de bereiding van dinor-cholestaan-derivaten.
NL176171C (nl) Werkwijze voor de bereiding van anti-adrenerge verbindingen en voor de bereiding van preparaten die ze bevatten.
NL148319B (nl) Werkwijze voor de bereiding van herbicide verbindingen en preparaten die ze bevatten.
NL7608903A (nl) Werkwijze voor de bereiding van guanidine- -derivaten en van preparaten die ze bevatten.
NL152248B (nl) Werkwijze voor de bereiding van complexen van alfa-6-deoxy-5-hydroxytetracycline.
NL167970C (nl) Werkwijze voor het bereiden van neriifolinederivaten en van therapeutische preparaten, die dergelijke derivaten bevatten, alsmede gevormde therapeutische preparaten.
NL175063C (nl) Werkwijze ter bereiding van 11,11-alkylideensteroiden, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
NL7501886A (nl) Werkwijze voor de bereiding van nieuwe zoetstof- fen en van preparaten die ze bevatten.
NL178255C (nl) Werkwijze voor de bereiding van aryloxypropylpiperazine-derivaten, met deze werkwijze gevormde voortbrengselen en werkwijze voor de bereiding van preparaten die ze bevatten.
NL162902C (nl) Werkwijze voor de bereiding van oxaprostaglandien- -analoga en voor de bereiding van farmaceutische prepa- raten die ze bevatten.
NL150457B (nl) Werkwijze voor de bereiding van bactericide stoffen en preparaten.
NL7605385A (nl) Werkwijze voor de bereiding van 3-nitropyrazool- -derivaten en van preparaten die ze bevatten.
NL168497B (nl) Werkwijze voor de bereiding van 2-(o-anilino-fenyl) ethaanderivaten, werkwijze ter bereiding van farma- ceutische preparaten, die deze verbindingen bevatten en verkregen farmaceutische preparaten.
NL7610761A (nl) Werkwijze voor de bereiding van prostaglandinen en van preparaten die ze bevatten.

Legal Events

Date Code Title Description
V4 Discontinued because of reaching the maximum lifetime of a patent